ESR1 and neoplasm: We further verified the anti-tumor activity of PCI-24781 treatment in MDA-MB-231, T-47D, and ER-positive primary breast tumor cells by detecting apoptosis, cell proliferation, cell growth, cell invasion, and cell migration (Figure S2A).